UnknownNot Applicable

Medical Thoracoscopy in Treatment Outcomes of Empyema Management

100 participantsStarted 2023-12-24

Plain-language summary

To evaluate the efficacy of drainage achieved by thoracoscopy vs tube drainage alone. To compare clinical outcomes such as length of hospital stay, need for additional procedures, and treatment failure rates between the two drainage methods. To asses resolution of pleural infection and rates of fluid re-accumulation over follow-up. To compare safety profiles and complication rates of thoracoscopy versus tube drainage alone

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed diagnosis of empyema via Imaging tests (e.g. chest x-ray/CT scan) * Age 18 years or older * Clinical signs/symptoms consistent with Empyema such as fever, chest pain, coughs * Pleural fluid loculations/septations seen on Imaging requiring drainage * No previous drainage procedures done for Current empyema Exclusion Criteria: * Age less than 18 years * Immunocompromised state or other conditions Contraindications to thoracoscopy * Previous drainage procedure for current Empyema * Residual pleural fluid not amenable to drain

What they're measuring

Treatment success:

Timeframe: baseline

Trial details

NCT IDNCT06132997

SponsorHend Mohamed Sayed Mohamed

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-28

Contact for this trial

Hend saleh, MD

01098988712 hend.m.saleh@gmail.com

View on ClinicalTrials.gov More Empyema trials